Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376 · see citing works

The endogenous cannabinoid system controls extinction of aversive memories

Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1‐like immunoreactivity, in the central nervous system of the rat and human

Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850 · see citing works

An endocannabinoid mechanism for stress-induced analgesia

Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · see citing works

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679 · see citing works

Pain modulation by release of the endogenous cannabinoid anandamide

Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 486 · see citing works

Descending modulation in persistent pain: an update

Ren, K., & Dubner, R. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00368-8 · Cited by 427 · see citing works

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works

Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes

Bisogno, T., Maurelli, S., Melck, D. J., PETROCELLIS, L. D., & Marzo, V. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 367 · see citing works

Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 329 · see citing works

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

Herzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · see citing works

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works

Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors

Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 293 · see citing works

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287 · see citing works

Endovanilloid signaling in pain

Marzo, V. D. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00340-9 · Cited by 272 · see citing works

Spinal and Supraspinal Mechanisms of Neuropathic Pain

Ossipov, M. H., Lai, J. Y., Malan, T. P., & Porreca, F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06673.x · Cited by 265 · see citing works

Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli.

Segal, M. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012628 · Cited by 247 · see citing works

Animal and cellular models of chronic pain

Wang, L. X., & Wang, Z. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00098-x · Cited by 220 · see citing works

Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain

Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207 · see citing works

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

PETROCELLIS, L. D., Davis, J. B., & Marzo, V. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02934-9 · Cited by 204 · see citing works

The endogenous cannabinoid system and its role in nociceptive behavior

Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203 · see citing works

Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats

Lim, G., Sung, B., Ji, R.-R., & Mao, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00242-2 · Cited by 195 · see citing works

Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice

Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Marzo, V. D., Baker, D., & Greensmith, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 164 · see citing works

Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

Barnes, M. P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.5.607 · Cited by 161 · see citing works

Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats

Kanai, Y., Nakazato, E., Fujiuchi, A., Hara, T., & Imai, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.003 · Cited by 149 · see citing works

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies

Darmani, N. A., Izzo, A. A., Degenhardt, B. F., Valenti, M., Scaglione, G., Capasso, R., Sorrentini, I., & Marzo, V. D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.001 · Cited by 144 · see citing works

The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling

Haj‐Dahmane, S., & Shen, R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3258-04.2005 · Cited by 136 · see citing works

Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids

Wallace, V. C. J., Cottrell, D. F., Brophy, P. J., & Fleetwood-Walker, S. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03221.2003 · Cited by 134 · see citing works

A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats

Pascual, D., Goicoechea, C., Suardíaz, M., & Martín, M. I. (2005) · Pain · doi:10.1016/j.pain.2005.07.008 · Cited by 117 · see citing works

Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice

Witting, A., Weydt, P., Hong, S. Y., Kliot, M., Möller, T., & Stella, N. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02544.x · Cited by 112 · see citing works

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat

Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 101 · see citing works

Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]

La Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R. A., Cuomo, V., Iacono, A., Raso, G. M., Meli, R., Piomelli, D., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100792 · Cited by 97 · see citing works

Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain

Costa, B., Colleoni, M., Conti, S., Trovato, A. E., Bianchi, M., Sotgiu, M. L., & Giagnoni, G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705587 · Cited by 89 · see citing works

Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

Palazzo, E., De Novellis, V., Petrosino, S., Marabese, I., Vita, D., Giordano, C., Di Marzo, V., Mangoni, G. S., Rossi, F., & Maione, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05086.x · Cited by 86 · see citing works

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 85 · see citing works

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat

Helyes, Z., Németh, J., Thán, M., Bölcskei, K., Pintér, E., & Szolcsányi, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00651-9 · Cited by 85 · see citing works

The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats

Ulugöl, A., Karadağ, Ç. H., İpçi, Y., Tamer, M., & Dökmeci, İ. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.061 · Cited by 73 · see citing works

Phosphorylation-Dependent Desensitization by Anandamide of Vanilloid Receptor-1 (TRPV1) Function in Rat Skeletal Muscle Arterioles and in Chinese Hamster Ovary Cells Expressing TRPV1

Lizanecz, E., Bagi, Z. A., Pásztor, E. T., Papp, Z. L., Edes, I. F., Kedei, N., Blumberg, P. M., & Tóth, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015644 · Cited by 70 · see citing works

3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects

De Vry, J., Denzer, D., Reissmueller, E., Eijckenboom, M., Heil, M., Meier, H., & Mauler, F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062836 · Cited by 63 · see citing works

Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes

Walczak, J., Pichette, V., Leblond, F., Desbiens, K., & Beaulieu, P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20821 · Cited by 62 · see citing works

Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect

Doğrul, A., Gül, H., Yıldız, O., Bilgin, F., & Güzeldemir, M. E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.060 · Cited by 61 · see citing works

Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors

Kelley, B. G., & Thayer, S. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.011 · Cited by 42 · see citing works

Cannabinoids and Neuropathic Pain

Goya, P., Jagerovic, N., Hernández‐Folgado, L., & Martín, M. (2003) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557033487818 · Cited by 32 · see citing works

Dorsal raphe nucleus and locus coeruleus neural networks and the elaboration of the sweet-substance-induced antinociception

Kishi, R., Bongiovanni, R., de Nadai, T. R., de Freitas, R. L., de Oliveira, R., Ferreira, C. M. D. R., & Coimbra, N. C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.046 · Cited by 20 · see citing works

The effect of pain on cognitive function: A review of clinical and preclinical research

Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122 · see citing works

Targeting the endocannabinoid system: to enhance or reduce?

Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798 · see citing works

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476 · see citing works

Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives

Saturnino, C., Popolo, A., Ramunno, A., Adesso, S., Pecoraro, M., Plutino, M. R., Rizzato, S., Albinati, A., Marzocco, S., Sala, M., et al. (2017) · Molecules · doi:10.3390/molecules22040616 · Cited by 449 · see citing works

Cannabinoids and Pain: New Insights From Old Molecules

Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 417 · see citing works

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Iannotti, F. A., Marzo, V. D., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 357 · see citing works

Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · see citing works

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

Petrosino, S., & Marzo, V. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 333 · see citing works

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors

Costa, B., Comelli, F., Bettoni, I., Colleoni, M., & Giagnoni, G. (2008) · Pain · doi:10.1016/j.pain.2008.06.003 · Cited by 286 · see citing works

Mast cells, glia and neuroinflammation: partners in crime?

Skaper, S. D., Facci, L., & Giusti, P. (2013) · Immunology · doi:10.1111/imm.12170 · Cited by 251 · see citing works

Hemopressin is an inverse agonist of CB 1 cannabinoid receptors

Heimann, A. S., Gomes, I., Dale, C. S., Pagano, R. L., Gupta, A., Souza, L. L., Luchessi, A. D., de Castro, L. M., Giorgi, R., Rioli, V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706980105 · Cited by 242 · see citing works

The Role of the Endocannabinoid System in Pain

Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 205 · see citing works

Neurotrophins and Neuropathic Pain: Role in Pathobiology

Khan, N., & Smith, M. T. (2015) · Molecules · doi:10.3390/molecules200610657 · Cited by 199 · see citing works

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain

Roques, B. P., Fournié‐Zaluski, M., & Wurm, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3673 · Cited by 193 · see citing works

Crucial Role of CB₂Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195 · see citing works

Analgesic actions of N ‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

Maione, S., PETROCELLIS, L. D., de Novellis, V., Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F., Woodward, D. F., & Marzo, V. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707145 · Cited by 195 · see citing works

Animal models of chronic pain: Advances and challenges for clinical translation

Burma, N. E., Leduc‐Pessah, H., Fan, C. Y., & Trang, T. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23768 · Cited by 198 · see citing works

Cannabinoids and Pain: Sites and Mechanisms of Action

Starowicz, K., & Finn, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 192 · see citing works

Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review

Skaper, S. D., Facci, L., & Giusti, P. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130224206 · Cited by 168 · see citing works

Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation

Schlosburg, J. E., Kinsey, S. G., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9075-y · Cited by 165 · see citing works

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls

Buczynski, M. W., & Parsons, L. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00787.x · Cited by 160 · see citing works

Palmitoylethanolamide in CNS health and disease

Raso, G. M., Russo, R., Calignano, A., & Meli, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.006 · Cited by 148 · see citing works

Role of different brain areas in peripheral nerve injury-induced neuropathic pain

Jaggi, A. S., & Singh, N. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.002 · Cited by 147 · see citing works

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 145 · see citing works

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Kunos, G., Osei‐Hyiaman, D., Bátkai, S., Sharkey, K. A., & Makriyannis, A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.001 · Cited by 137 · see citing works

Interferon-γ Is a Critical Modulator of CB2Cannabinoid Receptor Signaling during Neuropathic Pain

Rácz, I., Nadal, X., Alferink, J., Baños, J.-E., Rehnelt, J., Martín, M., Pintado, B., Gutiérrez‐Adán, A., Sanguino, E., Bellora, N., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3402-08.2008 · Cited by 134 · see citing works

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia

D’Agostino, G., Rana, G. L., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., LoVerme, J., Piomelli, D., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.022 · Cited by 134 · see citing works

Minocycline Treatment Inhibits Microglial Activation and Alters Spinal Levels of Endocannabinoids in a Rat Model of Neuropathic Pain

Guasti, L., Richardson, D. S., Jhaveri, M. D., Eldeeb, K., Barrett, D. A., Elphick, M. R., Alexander, S. P. H., Kendall, D. A., Michael, G. J., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-35 · Cited by 133 · see citing works

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice

Guida, F., Luongo, L., Marmo, F., Romano, R., Iannotta, M., Napolitano, F., Belardo, C., Marabese, I., D’Aniello, A., Gregorio, D. D., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0139-5 · Cited by 128 · see citing works

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 126 · see citing works

The endocannabinoid system is modulated in response to spinal cord injury in rats

García‐Ovejero, D., Arévalo‐Martín, Á., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., Watanabe, M., Guaza, C., Marzo, V. D., & Molina‐Holgado, E. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.015 · Cited by 125 · see citing works

Harnessing the anti-inflammatory potential of palmitoylethanolamide

Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 122 · see citing works

Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain

Sagar, D. R., Staniaszek, L. E., Okine, B. N., Woodhams, S. G., Norris, L. M., Pearson, R. G., Garle, M. J., Alexander, S. P. H., Bennett, A. J., Barrett, D. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27698 · Cited by 119 · see citing works

Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms

Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · see citing works

Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis

Varrassi, G. (2016) · Pain Physician · doi:10.36076/ppj/2016.19.11 · Cited by 116 · see citing works

Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.014 · Cited by 116 · see citing works

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice

Luongo, L., Palazzo, E., Tambaro, S., Giordano, C. S. D. S., Gatta, L., Scafuro, M. A., Rossi, F., Lazzari, P., Pani, L., de Novellis, V., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.021 · Cited by 113 · see citing works

Cannabinoids and Multiple Sclerosis

Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 110 · see citing works

Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain

Guida, F., Boccella, S., Belardo, C., Iannotta, M., Piscitelli, F., Filippis, F. D., Paino, S., Ricciardi, F., Siniscalco, D., Marabese, I., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.006 · Cited by 111 · see citing works

Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability

Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., & Marzo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031111 · Cited by 110 · see citing works

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

Loría, F., Petrosino, S., Mestre, L., Spagnolo, A., Correa, F., Hernangómez, M., Guaza, C., Di Marzo, V., & Docagne, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06377.x · Cited by 109 · see citing works

Cannabinoids and the Brain

Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110 · see citing works

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

Skaper, S. D., Facci, L., Fusco, M., della Valle, M. F., Zusso, M., Costa, B., & Giusti, P. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0191-7 · Cited by 107 · see citing works

The role of endocannabinoids in pain modulation

Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 106 · see citing works

Enhanced endocannabinoid tone as a potential target of pharmacotherapy

Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 104 · see citing works

Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism

Starowicz, K., Makuch, W., Korostyński, M., Małek, N., Ślęzak, M., Żychowska, M., Petrosino, S., PETROCELLIS, L. D., Cristino, L., Przewłocka, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060040 · Cited by 97 · see citing works

Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia

Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 96 · see citing works

Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury

Esposito, E., Paterniti, I., Mazzon, E., Genovese, T., Paola, R. D., Galuppo, M., & Cuzzocrea, S. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.02.006 · Cited by 97 · see citing works

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55

Sharir, H., Console‐Bram, L., Mundy, C., Popoff, S. N., Kapur, A., & Abood, M. E. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9351-6 · Cited by 96 · see citing works

Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain and in the Spinal Cord: Circuitries and Neurochemistry

Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 95 · see citing works

Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries

Esposito, E., & Cuzzocrea, S. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010010 · Cited by 92 · see citing works

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone

Olango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 91 · see citing works

The Neurobiology of Pain Perception in Normal and Persistent Pain

Fenton, B. W., Shih, E., & Zolton, J. R. (2015) · Pain Management · doi:10.2217/pmt.15.27 · Cited by 90 · see citing works

Evidence for a novel functional role of cannabinoid CB₂ receptors in the thalamus of neuropathic rats

Jhaveri, M. D., Elmes, S. J. R., Richardson, D., Barrett, D. A., Kendall, D. A., Mason, R., & Chapman, V. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06162.x · Cited by 88 · see citing works

CB₁Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

Brusberg, M., Arvidsson, S., Kang, D., Larsson, H., Lindström, E., & Martinez, V. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-08.2009 · Cited by 88 · see citing works

The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress

Corcoran, L., Roche, M., & Finn, D. P. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.003 · Cited by 86 · see citing works

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect

Petrosino, S., Cordaro, M., Verde, R., Moriello, A. S., Marcolongo, G., Schievano, C., Siracusa, R., Piscitelli, F., Peritore, A. F., Crupi, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00249 · Cited by 89 · see citing works

From endocannabinoid profiling to ‘endocannabinoid therapeutics’

Ligresti, A., Petrosino, S., & Marzo, V. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.615 · Cited by 85 · see citing works

Spinal Cord Injuries Induce Changes in CB 1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions

Knerlich‐Lukoschus, F., Noack, M., von der Ropp‐Brenner, B., Lucius, R., Mehdorn, H. M., & Held‐Feindt, J. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1652 · Cited by 78 · see citing works

The Role of Cannabinoid Receptors in the Descending Modulation of Pain

Palazzo, E., Luongo, L., de Novellis, V., Rossi, F., & Maione, S. (2010) · Pharmaceuticals · doi:10.3390/ph3082661 · Cited by 78 · see citing works

Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury

Figueroa, J. D., Cordero, K., Serrano‐Illán, M., Almeyda, A. R., Baldeosingh, K., Almaguel, F. G., & León, M. A. D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.012 · Cited by 78 · see citing works

Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate

Rea, K., Roche, M., & Finn, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707440 · Cited by 79 · see citing works

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

Petrosino, S., Moriello, A. S., Verde, R., Allarà, M., Imperatore, R., Ligresti, A., Mahmoud, A. M., Peritore, A. F., Iannotti, F. A., & Marzo, V. D. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1671-5 · Cited by 76 · see citing works

“Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control

Piscitelli, F., & Marzo, V. D. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300015x · Cited by 74 · see citing works

Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms

Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Marzo, V. D., & Przewłocka, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.021 · Cited by 74 · see citing works

Macrophage-derived lipid agonists of PPAR-αas intrinsic controllers of inflammation

Pontis, S., Ribeiro, A., Sasso, O., & Piomelli, D. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1092944 · Cited by 74 · see citing works

6-Methoxy-N-alkyl Isatin Acylhydrazone Derivatives as a Novel Series of Potent Selective Cannabinoid Receptor 2 Inverse Agonists: Design, Synthesis, and Binding Mode Prediction

Diaz, P., Phatak, S. S., Xu, J. J., Astruc‐Diaz, F., Cavasotto, C. N., & Naguib, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801353p · Cited by 71 · see citing works

Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.

Haj-Dahmane, S., & Shen, R.-Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.153858 · Cited by 69 · see citing works

Cannabis and pain: a scoping review

Pantoja‐Ruiz, C., Restrepo-Jiménez, P., Castañeda‐Cardona, C., Ferreirós, A., & Rosselli, D. (2021) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2021.06.018 · Cited by 76 · see citing works

Endocannabinoids and neuropathic pain: focus on neuron–glia and endocannabinoid–neurotrophin interactions

Luongo, L., Maione, S., & Marzo, V. D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12440 · Cited by 69 · see citing works

Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons

Veress, G., Mészár, Z., Muszil, D., Avelino, A., Matesz, K., Mackie, K., & Nagy, I. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0425-2 · Cited by 67 · see citing works

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review

Petrosino, S., & Moriello, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249526 · Cited by 68 · see citing works

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far

Flores, Á., Maldonado, R. J., & Berrendero, F. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00256 · Cited by 68 · see citing works

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

Wallace, V. C. J., Segerdahl, A. R., Lambert, D. M., Vandevoorde, S., Blackbeard, J., Pheby, T., Hasnie, F., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707326 · Cited by 66 · see citing works

Basal and Fasting/Refeeding‐regulated Tissue Levels of Endogenous PPAR‐α Ligands in Zucker Rats

Izzo, A. A., Piscitelli, F., Capasso, R., Marini, P., Cristino, L., Petrosino, S., & Marzo, V. D. (2009) · Obesity · doi:10.1038/oby.2009.186 · Cited by 66 · see citing works

Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide

Bettoni, I., Comelli, F., Colombo, A., Bonfanti, P., & Costa, B. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010008 · Cited by 66 · see citing works

Endocannabinoid system and pain: an introduction

Burston, J. J., & Woodhams, S. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003650 · Cited by 65 · see citing works

Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat

Greco, R., Gasperi, V, Sandrini, G., Bagetta, G., Nappi, G., Maccarrone, M., & Tassorelli, C. (2010) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01924.x · Cited by 64 · see citing works

Modulation of the anti‐nociceptive effects of 2‐arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model

Desroches, J., Guindon, J., Lambert, C., & Beaulieu, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.322 · Cited by 63 · see citing works

The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy

Rossi, F., Bellini, G., Luongo, L., Torella, M., Mancusi, S., PETROCELLIS, L. D., Petrosino, S., Siniscalco, D., Orlando, P., Scafuro, M., et al. (2011) · Bone · doi:10.1016/j.bone.2011.01.001 · Cited by 63 · see citing works

Implication of allopregnanolone in the antinociceptive effect of N -palmitoylethanolamide in acute or persistent pain

Sasso, O., Russo, R., Vitiello, S., Raso, G. M., D’Agostino, G., Iacono, A., Rana, G. L., Vallée, M., Cuzzocrea, S., Piazza, P. V., et al. (2011) · Pain · doi:10.1016/j.pain.2011.08.010 · Cited by 62 · see citing works

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain

D’Amico, R., Impellizzeri, D., Cuzzocrea, S., & Paola, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155330 · Cited by 62 · see citing works

Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases

Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 60 · see citing works

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system

Starowicz, K., & Przewłocka, B. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0392 · Cited by 57 · see citing works

Neuroplasticity of Supraspinal Structures Associated with Pathological Pain

Boadas‐Vaello, P., Homs, J., Reina, F., Carrera, A., & Verdú, E. (2017) · The Anatomical Record · doi:10.1002/ar.23587 · Cited by 58 · see citing works

Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain

Hama, A. T., & Sagen, J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.031 · Cited by 56 · see citing works

Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders

Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 56 · see citing works

Acute Reduction of Anandamide‐Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication‐Overuse Headache Subjects After Withdrawal Treatment

Perrotta, A., Arce‐Leal, N., Tassorelli, C., Gasperi, V., Sances, G., Blandini, F., Serrao, M., Bolla, M., Pierelli, F., Nappi, G., et al. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02170.x · Cited by 55 · see citing works

Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity

de Novellis, V., Luongo, L., Guida, F., Cristino, L., Palazzo, E., Russo, R., Marabese, I., D’Agostino, G., Calignano, A., Rossi, F., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.034 · Cited by 52 · see citing works

Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception

Dogrul, A. B., Seyrek, M., Yalçın, B., & Ulugöl, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.007 · Cited by 52 · see citing works

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 52 · see citing works

Cannabinoid receptors and pain

Starowicz, K., Małek, N., & Przewłocka, B. (2013) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.83 · Cited by 50 · see citing works

Simultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis

Wong, A., Sagar, D. R., Ortori, C. A., Kendall, D. A., Chapman, V., & Barrett, D. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048694 · Cited by 48 · see citing works

Endocannabinoid‐dependent plasticity at spinal nociceptor synapses

Kato, A., Punnakkal, P., Pernía‐Andrade, A. J., von Schoultz, C., Sharopov, S., Nyilas, R., Katona, I., & Zeilhofer, H. U. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.234229 · Cited by 49 · see citing works

Cannabinoids in the descending pain modulatory circuit: Role in inflammation

Bouchet, C. A., & Ingram, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107495 · Cited by 51 · see citing works

Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial

Andresen, S. R., Bing, J., Hansen, R. M., Biering‐Sørensen, F., Johannesen, I. L., Hagen, E. M., Rice, A. S. C., Nielsen, J. F., Bach, F. W., & Finnerup, N. B. (2016) · Pain · doi:10.1097/j.pain.0000000000000623 · Cited by 49 · see citing works

Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception

Williams, J., Haller, V. L., Stevens, D. L., & Welch, S. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.035 · Cited by 45 · see citing works

Does Exercise Make Migraines Worse and Tension Type Headaches Better?

Hindiyeh, N. A., Krusz, J. C., & Cowan, R. P. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0380-5 · Cited by 45 · see citing works

Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain

Li, M., Suchland, K. L., & Ingram, S. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1310-16.2016 · Cited by 44 · see citing works

Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

Palazzo, E., De Novellis, V., Petrosino, S., Marabese, I., Vita, D., Giordano, C., Di Marzo, V., Mangoni, G. S., Rossi, F., & Maione, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05086.x · Cited by 86 · see citing works

Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain

Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207 · see citing works

Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats

Dean, C., Hillard, C. J., Seagard, J. L., Hopp, F. A., & Hogan, Q. H. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2016 · Cited by 9 · see citing works

Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain

Sagar, D. R., Jhaveri, M. D., Richardson, D. S., Gray, R., de Lago, E., Fernández‐Ruíz, J., Barrett, D. A., Kendall, D. A., & Chapman, V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07162.x · Cited by 30 · see citing works

Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms

Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Marzo, V. D., & Przewłocka, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.021 · Cited by 74 · see citing works